To understand the reasons underlying these alterations, we observe that in our CRC–CRN the degradation of p53 is regulated by the phosphorylated form of MDM2, whose activation is in turn regulated by phospho-AKT (p-AKT)40. This evidence concerns the gene TP53 and colorectal carcinoma.